About
Solution
News
Contact
Selecting LVO stroke patients for rapid treatment
Differentiation between ischemic and haemorrhagic stroke
Detection of mild Traumatic Brain Injury
About the founders
Board of directors & leadership team
News
4.11.2024
ABCDx to Showcase Innovative Stroke Detection Solution at Barcelona Deep Tech Summit 2024
Discover more
Discover more
5.9.2024
H-FABP as a Biomarker for Transient Ischemic Attack
Discover more
Discover more
6.6.2024
Groundbreaking Study Identifies Promising Biomarkers for Pediatric Mild Traumatic Brain Injury
Discover more
Discover more
18.4.2024
ABCDx Was Awarded Prestigious Spot in EIC USA Soft-Landing Program for Health and Life Sciences
Discover more
Discover more
6.3.2024
Collaboration between ABCDx and Andalusian Hospitals
Discover more
Discover more
14.2.2024
ABCDx research collaboration milestone: BIOSHIP-training study concludes the recruitment phase
Discover more
Discover more
9.2.2024
ABCDx Collaborates in Eureka Consortium for a Landmark Clinical Study in Stroke Diagnosis
Discover more
Discover more
23.1.2024
ABCDx Announces Strategic Partnership with Extra Horizon to Develop Cutting-Edge LVOCheck Digital Platform
Discover more
Discover more
12.1.2024
ABCDx and Veranex Announce Strategic Partnership to Evaluate and Advance Groundbreaking Stroke Diagnostic Tool ‘LVOcheck’
Discover more
Discover more
4.12.2023
ABCDx and BBI Solutions Successfully Complete Initial Phases of LVOCheck Rapid Test Development
Discover more
Discover more
22.11.2023
ABCDx and VHIR Enter Strategic Co-Ownership Agreement
Discover more
Discover more
25.10.2023
Agreement ABCDx – FISEVI for the study of stroke biomarkers
Discover more
Discover more
24.10.2023
ABCDx Introduces Groundbreaking Diagnostic Tool: TIACheck
Discover more
Discover more
18.10.2023
ABCDx Achieves Significant Milestone in LVO Patient Triage
Discover more
Discover more
5.2.2023
BioShip-Training Kick off meeting
Discover more
Discover more
11.11.2022
company ABCDx announce the final development and CE marking of its BRAINCheck™ App technology.
Discover more
Discover more
15.9.2021
ABCDx granted EUR 2.4M by Eurostars European Funding Programme
Discover more
Discover more
15.9.2021
ABCDx granted EUR 2.4M by Eurostars European Funding Programme
Discover more
Discover more
8.6.2021
New publication in Neurology describes ABCDx blood biomarkers to differentiate ischemic and haemorrhagic strokes
Discover more
Discover more
22.5.2020
New Patent License for StrokeCheck
Discover more
Discover more
1.5.2020
New Review on Stroke Biomarkers
Discover more
Discover more
14.4.2020
ABCDx biomarkers for trauma outcome
Discover more
Discover more
12.2.2020
ABCDx very pround to confirm in BILAN its innovation discoveries in stroke.
Discover more
Discover more
2.2.2020
ABCDx secures Eurostars funding to develop PolarTBICheck for early diagnosis and treatment of sports-related concussions
Discover more
Discover more
20.11.2019
First patient included in the BIO-FAST study
Discover more
Discover more
18.11.2019
ABCDx at NNC conference in Lund
Discover more
Discover more
17.11.2019
ABCDx at Medica Düsseldorf
Discover more
Discover more
10.11.2019
ABCDx participates to BIOEUROPE in Hamburg
Discover more
Discover more
25.9.2019
Grant for multi-centric study
Discover more
Discover more
24.9.2019
ABCDx at Sachs Conference
Discover more
Discover more
13.9.2019
ABCDx signs partnership agreement with PolarCool for TBICheck ™ covering the Nordic market
Discover more
Discover more
13.8.2019
Publication on early detection of Stroke-Associated Pneumonia (SAP)
Discover more
Discover more
3.7.2019
New biomarkers discovered as predictive for TBI patient outcome
Discover more
Discover more
2.8.2018
ABCDx Sponsor of the Swiss Symposium in POC Diagnostics 2018
Discover more
Discover more
hi
Discover more
Discover more